Recap AMCP 2024: Our thought leadership in action
From delivering educational sessions on the evolution of the AMCP format for formulary submissions and the role of pre-approval dossiers in a successful product launch to award-winning research, Cencora was a proud supporter of this year's conference.
Explore some of our expert contributions and related content that showcased our commitment to helping our biopharma partners accelerate product success.
- Changes in US payer biosimilar coverage policies of granulocyte colony stimulating factor products
- Early implementation of PIE for specific drug categories
- Mind the “pre-approval” gap: Payer pre-approval information needs and how manufacturers can better meet them
- Sourcing value: understanding payer perceptions of value assessment information for formulary decision-making
- US payer perceptions on formulary evaluation and management of cell and gene therapies
- Beyond value assessment reports: a review of payer perspectives on ICER’s initiatives and tools
- Impact of route of administration on access and reimbursement of cell and gene therapies: a survey of US payers
FormularyDecisions®
Innovation and Impact Award
The Innovation and Impact Award serves as a beacon of recognition for those who have demonstrated exceptional support for healthcare decision makers needs in formulary decision making. It is awarded annually to distinguished recipients in two distinct categories: mid-to-large biopharma and emerging biopharma.
Congratulations to SpringWorks Therapeutics (Emerging biopharma category) and AbbVie Inc (Mid-to-large biopharma category).
We were thrilled to recognize SpringWorks Therapeutics with the Emerging biopharma company Innovation and Impact Award at AMCP Annual 2024.
Learn more about SpringWorks Therapeutics’ approach to digital engagement with healthcare decision makers, and how FormularyDecisions fits into their digital strategy, in this interview with Zack McCormack, Director, Value and Access.
Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.
Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.